Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sylvia W A Kamerling"'
Autor:
Laura S. van Dam, Jelle M. Oskam, Sylvia W. A. Kamerling, Eline J. Arends, O. W. Bredewold, Magdalena A. Berkowska, Jacques J. M. van Dongen, Ton J. Rabelink, Cees van Kooten, Y. K. Onno Teng
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
BackgroundB-cell depletion with rituximab (RTX) is an effective treatment for anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) patients. Nevertheless, relapses are frequent after RTX, often preceded by B-cell repopulation sug
Externí odkaz:
https://doaj.org/article/88a01c1caada4b079f0609fa32b551e0
Autor:
Eline J Arends, Mihaela Zlei, Christopher M Tipton, Zgjim Osmani, Fenna de Bie, Sylvia W A Kamerling, Ton Rabelink, Ignacio Sanz, Jacques J M Van Dongen, Cees van Kooten, Yeo K O Teng
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Belimumab (BEL), a recombinant human monoclonal antibody directed against B-cell activating factor (BAFF), is the first approved biological agent for patients with systemic lupus erythematosus (SLE) and a high level of disease act
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a0b41e245dac5f8927ca6389dc0c352
https://doi.org/10.1093/ndt/gfac067.045
https://doi.org/10.1093/ndt/gfac067.045
Autor:
Jan-Willem Eijgenraam, Susanne M. Reinartz, Sylvia W. A. Kamerling, Vanessa J. van Ham, Kim Zuidwijk, Cornelis M. van Drunen, Mohamed R. Daha, Wytske J. Fokkens, Cees van Kooten
Publikováno v:
Nephrology Dialysis Transplantation; Feb2008, Vol. 23 Issue 2, p612-612, 1p